Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-κB pathway

Frontiers in Microbiology

Volumn 8, Issue FEB, 2017, Pages

  Breyner, Natalia M ^a   Michon, Cristophe ^a   de Sousa, Cassiana S ^a,b   Vilas Boas, Priscilla B ^a,b   Chain, Florian ^a   Azevedo, Vasco A ^b   Langella, Philippe ^a   Chatel, Jean M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Colitis models; Faecalibacterium prausnitzii; Inflammation; Lactococcus lactis; MAM (Microbial Anti inflammatory Molecule); NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; BENZENE DERIVATIVE; COMPLEMENTARY DNA; CYTOKINE; DEXTRAN SULFATE; DINITROBENZENE SULFATE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 14; INTERLEUKIN 17; INTERLEUKIN 5; LUCIFERASE; RECOMBINANT MICROBIAL ANTIINFLAMMATORY MOLECULE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FAECALIBACTERIUM PRAUSNITZII; IMMUNE RESPONSE; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PLASMID; PROMOTER REGION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 85014482513     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00114     Document Type: Article

References (26)

1. Almeida, J. F., Mariat, D., Azevedo, V., Miyoshi, A., de Moreno de LeBlanc, A., Del Carmen, S., et al. (2014). Correlation between fibronectin binding protein A expression level at the surface of recombinant Lactococcus lactis and plasmid transfer in vitro and in vivo. BMC Microbiol. 14:248. doi: 10.1186/s12866-014-0248-9.
2. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236. doi: 10.1038/nature12331.
3. Aubry, C., Michon, C., Chain, F., Chvatchenko, Y., Goffin, L., Zimmerli, S. C., et al. (2015). Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. Microb. Cell Fact. 14, 176. doi: 10.1186/s12934-015-0367-5.
4. Chassaing, B., Aitken, J. D., Malleshappa, M., and Vijay-Kumar, M. (2014). Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol. 104:15.215. doi: 10.1002/0471142735.im1525s104.
5. Chatel, J. M., Pothelune, L., Ah-Leung, S., Corthier, G., Wal, J. M., and Langella, P. (2008). In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Ther. 15, 1184-1190. doi: 10.1038/gt.2008.59.
6. Cooper, H. S., Murthy, S. N., Shah, R. S., and Sedergran, D. J. (1993). Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249.
7. Del Carmen, S., Zurita-Turk, M., Lima, F. A., Coelho Dos Santos, J. S., Leclercq, S. Y., Chatel, J. M., et al. (2013). A novel Interleukin-10 DNA mucosal delivery system attenuates intestinal inflammation in a mouse model. Eur. J. Inflamm. 11, 641-654. doi: 10.1177/1721727X1301100308.
8. Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., et al. (2009). The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689. doi: 10.1016/j.immuni.2009.08.020.
9. Innocentin, S., Guimaraes, V., Miyoshi, A., Azevedo, V., Langella, P., Chatel, J. M., et al. (2009). Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl. Environ. Microbiol. 75, 4870-4878. doi: 10.1128/AEM.00825-09.
10. Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., et al. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498. doi: 10.1016/j.cell.2009.09.033.
11. Kechaou, N., Chain, F., Gratadoux, J. J., Blugeon, S., Bertho, N., Chevalier, C., et al. (2013). Identification of one novel candidate probiotic lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Appl. Environ. Microbiol. 79, 1491-1499. doi: 10.1128/AEM.03075-12.
12. Kiesler, P., Fuss, I. J., and Strober, W. (2015). Experimental models of inflammatory bowel diseases. Cell Mol. Gastroenterol. Hepatol. 1, 154-170. doi: 10.1016/j.jcmgh.2015.01.006.
13. Martín, R., Chain, F., Miquel, S., Lu, J., Gratadoux, J. J., Sokol, H., et al. (2014). The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm. Bowel Dis. 20, 417-430. doi: 10.1097/01.MIB.0000440815.76627.64.
14. Martín, R., Miquel, S., Chain, F., Natividad J. M., Jury, J., Lu, J., et al. (2015). Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 15:67. doi: 10.1186/s12866-015-0400-1.
15. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., and Kasper, D. L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118. doi: 10.1016/j.cell.2005.05.007.
16. Mazmanian, S. K., Round, J. L., and Kasper, D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625. doi: 10.1038/nature07008.
17. Michon, C., Kuczkowska, K., Langella, P., Eijsink, V. G., Mathiesen, G., and Chatel, J. M. (2015). Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo. Microb. Cell Fact. 14, 95. doi: 10.1186/s12934-015-0366-6.
18. Miquel, S., Martin, R., Rossi, O., Bermudez-Humaran, L., Chatel, J., Sokol, H., et al. (2013). Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16, 255-261. doi: 10.1016/j.mib.2013.06.003.
19. Quévrain, E., Maubert, M. A., Michon, C., Chain, F., Marquant, R., Tailhades, J., et al. (2016a). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut. 65, 415-425. doi: 10.1136/gutjnl-2014-307649.
20. Quévrain, E., Maubert, M. A., Sokol, H., Devreese, B., and Seksik, P. (2016b). The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem. Gut 65, 882. doi: 10.1136/gutjnl-2015-311094.
21. Reyes, J. L., Lopes, F., Leung, G., Mancini, N. L., Matisz, C. E., Wang, A., et al. (2016). Treatment with cestode parasite antigens results in recruitment of CCR2+ myeloid cells, the adoptive transfer of which ameliorates colitis. Infect. Immun. 84, 3471-3483. doi: 10.1128/IAI.00681-16.
22. Round, J. L., and Mazmanian, S. K. (2017). Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 107, 12204-12209. doi: 10.1073/pnas.0909122107.
23. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi: 10.1073/pnas.0804812105.
24. Souza, B. M., Preisser, T. M., Pereira, V. B., Zurita-Turk, M., de Castro, C. P., da Cunha, V. P., et al. (2016). Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells. Microb. Cell Fact. 15, 150. doi: 10.1186/s12934-016-0548-x.
25. Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., and Polk, D. B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575. doi: 10.1053/j.gastro.2006.11.022.
26. Zhang, M., Qiu, X., Zhang, H., Yang, X., Hong, N., Yang, Y., et al. (2014). Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats. PLoS ONE 9:e109146. doi: 10.1371/journal.pone.0109146.